Phosphagenics Limited Stock Australian S.E.
Equities
AU000000POH7
Biotechnology & Medical Research
Sales 2022 | 1.13M 738K | Sales 2023 | 474K 309K | Capitalization | 11.09M 7.25M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.31M | Net income 2023 | -3M -1.96M | EV / Sales 2022 | 23.3 x |
Net cash position 2022 | 1.22M 798K | Net cash position 2023 | 5.33M 3.48M | EV / Sales 2023 | 12.2 x |
P/E ratio 2022 |
-11.5
x | P/E ratio 2023 |
-2.31
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.6% |
Managers | Title | Age | Since |
---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 01-12-31 |
Melanie Leydin
DFI | Director of Finance/CFO | 51 | 18-12-27 |
Roksan Libinaki
COO | Chief Operating Officer | - | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 15-01-13 |
Director/Board Member | 60 | 20-01-12 | |
Gregory Collier
CHM | Chairman | - | 15-04-12 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+45.32% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |